Literature DB >> 23886199

Hsa-miR-181a-5p expression and effects on cell proliferation in gastric cancer.

Gang Chen1, Zhi-Li Shen, Ling Wang, Chun-Ye Lv, Xin-En Huang, Rong-Ping Zhou.   

Abstract

PURPOSE: MicroRNAs (miRNAs) are small endogenous, non-coding, single-stranded RNAs (approximately 22 nt). Accumulating evidence has shown that aberrant miRNA expression is pronounced and correlated with gastric cancer genesis and progression.
MATERIALS AND METHODS: Expression levels of miR-181a-5p in GC tissues and cell lines were assessed by qRT-PCR and tested for correlation with clinical features. In addition, effects of miR-181a-5p on GC cell growth were investigated.
RESULTS: Our findings indicate that miR-181a-5p is upregulated in GC, in correlation with lymph node invasion, nerve invasion and vascular invasion (P<0.05). Enforced expression of miR-181a -5p promoted cell proliferation ability.
CONCLUSIONS: This study suggested that increased miR-181a-5p is related to GC progression. MiR-181a-5p may represent a potential therapeutic target for GC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23886199     DOI: 10.7314/apjcp.2013.14.6.3871

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  20 in total

Review 1.  miRNA polymorphisms and risk of gastric cancer in Asian population.

Authors:  Hai-Bing Hua; Ting-Ting Yan; Qing-Min Sun
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

2.  NanoStringDiff: a novel statistical method for differential expression analysis based on NanoString nCounter data.

Authors:  Hong Wang; Craig Horbinski; Hao Wu; Yinxing Liu; Shaoyi Sheng; Jinpeng Liu; Heidi Weiss; Arnold J Stromberg; Chi Wang
Journal:  Nucleic Acids Res       Date:  2016-07-28       Impact factor: 16.971

3.  Epigenetic modulation associated with carcinogenesis and prognosis of human gastric cancer.

Authors:  Fuminori Sonohara; Yoshikuni Inokawa; Masamichi Hayashi; Yasuhiro Kodera; Shuji Nomoto
Journal:  Oncol Lett       Date:  2017-03-27       Impact factor: 2.967

Review 4.  MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.

Authors:  Christiane Matuszcak; Joerg Haier; Richard Hummel; Kirsten Lindner
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

5.  Can mild cognitive impairment and Alzheimer's disease be diagnosed by monitoring a miRNA triad in the blood?

Authors:  Zhuang-Yao D Wei; Ashok K Shetty
Journal:  Aging Cell       Date:  2022-05-10       Impact factor: 11.005

6.  Grouping miRNAs of similar functions via weighted information content of gene ontology.

Authors:  Chaowang Lan; Qingfeng Chen; Jinyan Li
Journal:  BMC Bioinformatics       Date:  2016-12-22       Impact factor: 3.169

7.  miR-181a decelerates proliferation in cutaneous squamous cell carcinoma by targeting the proto-oncogene KRAS.

Authors:  Johannes Neu; Piotr Jan Dziunycz; Andreas Dzung; Karine Lefort; Martin Falke; Rémy Denzler; Sandra Nicole Freiberger; Guergana Iotzova-Weiss; Aleksandar Kuzmanov; Mitchell Paul Levesque; Gian-Paolo Dotto; Günther Franz L Hofbauer
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

8.  Effects of lncRNA ANRIL-knockdown on the proliferation, apoptosis and cell cycle of gastric cancer cells.

Authors:  Xueqian Hu; Ting Lou; Chunying Yuan; Yongsheng Wang; Xiaolong Tu; Yi Wang; Tingsu Zhang
Journal:  Oncol Lett       Date:  2021-06-28       Impact factor: 2.967

9.  Differentially expressed wound healing-related microRNAs in the human diabetic cornea.

Authors:  Vincent A Funari; Michael Winkler; Jordan Brown; Slobodan D Dimitrijevich; Alexander V Ljubimov; Mehrnoosh Saghizadeh
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

10.  Gene Expression Analysis of the Effect of Ischemic Infarction in Whole Blood.

Authors:  Ayako Takuma; Arata Abe; Yoshikazu Saito; Chikako Nito; Masayuki Ueda; Yoshiro Ishimaru; Hideki Harada; Keiko Abe; Kazumi Kimura; Tomiko Asakura
Journal:  Int J Mol Sci       Date:  2017-11-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.